In the BioHarmony Drug Report Database
Gemifloxacin
Factive (gemifloxacin) is a small molecule pharmaceutical. Gemifloxacin was first approved as Factive on 2003-04-04. It is used to treat bacterial infections, bronchitis, community-acquired infections, gram-negative bacterial infections, and pneumococcal pneumonia amongst others in the USA.
Trade Name
|
Factive |
|---|---|
Common Name
|
gemifloxacin |
ChEMBL ID
|
CHEMBL430 |
Indication
|
bacterial infections, bronchitis, community-acquired infections, gram-negative bacterial infections, pneumococcal pneumonia, protozoan infections, urinary tract infections |
Drug Class
|
Antibacterials (quinolone derivatives) |
Image (chem structure or protein)